OneDigital Investment Advisors LLC Trims Stock Position in Becton, Dickinson and Company (NYSE:BDX)

OneDigital Investment Advisors LLC reduced its stake in Becton, Dickinson and Company (NYSE:BDX) by 4.0% during the 3rd quarter, HoldingsChannel reports. The firm owned 28,118 shares of the medical instruments supplier’s stock after selling 1,157 shares during the period. OneDigital Investment Advisors LLC’s holdings in Becton, Dickinson and Company were worth $6,779,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of the stock. Livelsberger Financial Advisory acquired a new position in Becton, Dickinson and Company during the 3rd quarter worth approximately $26,000. Ashton Thomas Securities LLC acquired a new position in Becton, Dickinson and Company during the third quarter worth $33,000. Tompkins Financial Corp raised its position in Becton, Dickinson and Company by 44.2% in the third quarter. Tompkins Financial Corp now owns 150 shares of the medical instruments supplier’s stock worth $36,000 after acquiring an additional 46 shares in the last quarter. Sound Income Strategies LLC lifted its holdings in Becton, Dickinson and Company by 35.8% in the third quarter. Sound Income Strategies LLC now owns 167 shares of the medical instruments supplier’s stock valued at $40,000 after acquiring an additional 44 shares during the period. Finally, Opal Wealth Advisors LLC purchased a new stake in shares of Becton, Dickinson and Company during the 2nd quarter worth $45,000. Institutional investors and hedge funds own 86.97% of the company’s stock.

Analysts Set New Price Targets

BDX has been the subject of a number of research analyst reports. Evercore ISI increased their price target on shares of Becton, Dickinson and Company from $286.00 to $290.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. StockNews.com upgraded Becton, Dickinson and Company from a “hold” rating to a “buy” rating in a report on Thursday, August 8th. Stifel Nicolaus lifted their price objective on Becton, Dickinson and Company from $270.00 to $280.00 and gave the stock a “buy” rating in a report on Friday, July 26th. Citigroup raised Becton, Dickinson and Company from a “neutral” rating to a “buy” rating and upped their target price for the company from $255.00 to $275.00 in a report on Tuesday, October 1st. Finally, Raymond James cut their price target on Becton, Dickinson and Company from $275.00 to $270.00 and set an “outperform” rating for the company in a research note on Friday, August 2nd. Eight analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $283.00.

Becton, Dickinson and Company Stock Performance

Becton, Dickinson and Company stock opened at $225.15 on Friday. Becton, Dickinson and Company has a fifty-two week low of $218.75 and a fifty-two week high of $249.89. The company has a market capitalization of $65.08 billion, a price-to-earnings ratio of 37.90, a PEG ratio of 1.72 and a beta of 0.43. The stock has a fifty day moving average of $236.44 and a two-hundred day moving average of $235.05. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.74 and a current ratio of 1.17.

Becton, Dickinson and Company (NYSE:BDX) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $3.81 EPS for the quarter, topping analysts’ consensus estimates of $3.77 by $0.04. The firm had revenue of $5.44 billion during the quarter, compared to analysts’ expectations of $5.38 billion. Becton, Dickinson and Company had a return on equity of 14.89% and a net margin of 8.55%. The firm’s quarterly revenue was up 6.9% compared to the same quarter last year. During the same quarter last year, the business posted $3.42 EPS. On average, analysts anticipate that Becton, Dickinson and Company will post 14.43 EPS for the current fiscal year.

Becton, Dickinson and Company Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 31st. Investors of record on Monday, December 9th will be paid a dividend of $1.04 per share. This is an increase from Becton, Dickinson and Company’s previous quarterly dividend of $0.95. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.16 annualized dividend and a dividend yield of 1.85%. Becton, Dickinson and Company’s dividend payout ratio is presently 63.97%.

About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.